237 related articles for article (PubMed ID: 33603756)
1. CBP Bromodomain Inhibition Rescues Mice From Lethal Sepsis Through Blocking HMGB1-Mediated Inflammatory Responses.
Bi X; Jiang B; Zhou J; Fan X; Yan X; Liang J; Luo L; Yin Z
Front Immunol; 2020; 11():625542. PubMed ID: 33603756
[TBL] [Abstract][Full Text] [Related]
2. Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses.
Bi X; Yan X; Jiang B; Liang J; Zhou J; Lu S; Liu J; Luo L; Yin Z
Toxicol Appl Pharmacol; 2021 Dec; 433():115778. PubMed ID: 34755645
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative effect of a rarely occurring C-methylrotenoid on HMGB1-induced septic responses in vitro and in vivo.
Yang EJ; Lee W; Song KS; Bae JS
Biochem Pharmacol; 2016 Jun; 110-111():58-70. PubMed ID: 27106082
[TBL] [Abstract][Full Text] [Related]
4. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function.
Tang D; Kang R; Xiao W; Zhang H; Lotze MT; Wang H; Xiao X
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):651-60. PubMed ID: 19265175
[TBL] [Abstract][Full Text] [Related]
5. LPS induces HMGB1 relocation and release by activating the NF-κB-CBP signal transduction pathway in the murine macrophage-like cell line RAW264.7.
Wu CX; Sun H; Liu Q; Guo H; Gong JP
J Surg Res; 2012 Jun; 175(1):88-100. PubMed ID: 21571302
[TBL] [Abstract][Full Text] [Related]
6. A dual-role of Gu-4 in suppressing HMGB1 secretion and blocking HMGB1 pro-inflammatory activity during inflammation.
Zhou H; Ji X; Wu Y; Xuan J; Qi Z; Shen L; Lan L; Li Q; Yin Z; Li Z; Zhao Z
PLoS One; 2014; 9(3):e89634. PubMed ID: 24603876
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 27 inhibits HMGB1 translocation by regulating CBP acetyltransferase activity and ubiquitination.
Bi X; Xu M; Li J; Huang T; Jiang B; Shen L; Luo L; Liu S; Yin Z
Mol Immunol; 2019 Apr; 108():45-55. PubMed ID: 30780033
[TBL] [Abstract][Full Text] [Related]
8. Persicarin is anti-inflammatory mediator against HMGB1-induced inflammatory responses in HUVECs and in CLP-induced sepsis mice.
Kim TH; Ku SK; Bae JS
J Cell Physiol; 2013 Apr; 228(4):696-703. PubMed ID: 22911316
[TBL] [Abstract][Full Text] [Related]
9. Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
Zhang Z; Zhang L; Zhou C; Wu H
Int Immunopharmacol; 2014 Nov; 23(1):14-26. PubMed ID: 25133650
[TBL] [Abstract][Full Text] [Related]
10. Methylthiouracil, a new treatment option for sepsis.
Kwak S; Ku SK; Kang H; Baek MC; Bae JS
Vascul Pharmacol; 2017 Jan; 88():1-10. PubMed ID: 26239884
[TBL] [Abstract][Full Text] [Related]
11. Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages.
Li L; Ling Y; Huang M; Yin T; Gou SM; Zhan NY; Xiong JX; Wu HS; Yang ZY; Wang CY
Cytokine; 2015 Mar; 72(1):36-42. PubMed ID: 25562836
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory activities of isorhamnetin-3-O-galactoside against HMGB1-induced inflammatory responses in both HUVECs and CLP-induced septic mice.
Kim TH; Ku SK; Bae JS
J Cell Biochem; 2013 Feb; 114(2):336-45. PubMed ID: 22930571
[TBL] [Abstract][Full Text] [Related]
13. Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice.
Chang KC
Thromb Res; 2015 Aug; 136(2):456-64. PubMed ID: 26116490
[TBL] [Abstract][Full Text] [Related]
14. Escin Increases the Survival Rate of LPS-Induced Septic Mice Through Inhibition of HMGB1 Release from Macrophages.
Cheng Y; Wang H; Mao M; Liang C; Zhang Y; Yang D; Wei Z; Gao S; Hu B; Wang L; Cai Q
Cell Physiol Biochem; 2015; 36(4):1577-86. PubMed ID: 26159678
[TBL] [Abstract][Full Text] [Related]
15. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice.
Yang Q; Liu X; Yao Z; Mao S; Wei Q; Chang Y
J Surg Res; 2014 Jan; 186(1):310-7. PubMed ID: 24124976
[TBL] [Abstract][Full Text] [Related]
16. Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality.
Coffey JC; Wang JH; Kelly R; Romics L; O'Callaghan A; Fiuza C; Redmond HP
J Leukoc Biol; 2007 Oct; 82(4):906-14. PubMed ID: 17626148
[TBL] [Abstract][Full Text] [Related]
17. 6,6'-Bieckol suppresses inflammatory responses by down-regulating nuclear factor-κB activation via Akt, JNK, and p38 MAPK in LPS-stimulated microglial cells.
Kim AR; Lee B; Joung EJ; Gwon WG; Utsuki T; Kim NG; Kim HR
Immunopharmacol Immunotoxicol; 2016 Jun; 38(3):244-52. PubMed ID: 27121731
[TBL] [Abstract][Full Text] [Related]
18. Levobupivacaine inhibits lipopolysaccharide-induced high mobility group box 1 release in vitro and in vivo.
Ge Y; Hu S; Zhang Y; Wang W; Xu Q; Zhou L; Mao H
J Surg Res; 2014 Dec; 192(2):582-91. PubMed ID: 25017707
[TBL] [Abstract][Full Text] [Related]
19. A tetrahydroisoquinoline alkaloid THI-28 reduces LPS-induced HMGB1 and diminishes organ injury in septic mice through p38 and PI3K/Nrf2/HO-1 signals.
Kim HS; Park EJ; Park SW; Kim HJ; Chang KC
Int Immunopharmacol; 2013 Nov; 17(3):684-92. PubMed ID: 24029593
[TBL] [Abstract][Full Text] [Related]
20. Inhibition effect of glycyrrhizin in lipopolysaccharide-induced high-mobility group box 1 releasing and expression from RAW264.7 cells.
Wu CX; He LX; Guo H; Tian XX; Liu Q; Sun H
Shock; 2015 Apr; 43(4):412-21. PubMed ID: 25526376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]